Skip to Main Content

GLOBUS MEDICAL INC

GMED Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
GMED Income Statement
GMED Balance Sheet
GMED Cash Flow
GMED Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GMED Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GMED Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by GMED's directors and management

Government lobbying spending instances

  • $10,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $10,000 Apr 20, 2020 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jan 21, 2020 Issue: Health Issues Medicare/Medicaid
  • $20,000 Oct 21, 2019 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 22, 2019 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jan 22, 2019 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $10,000 Oct 22, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $10,000 Jul 20, 2018 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $10,000 Oct 20, 2017 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $10,000 Jul 20, 2017 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $10,000 Apr 20, 2017 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $10,000 Jan 23, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $10,000 Oct 20, 2016 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $10,000 Jul 20, 2016 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $10,000 Apr 20, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $10,000 Jan 19, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $10,000 Oct 20, 2015 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $10,000 Apr 21, 2014 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jan 21, 2014 Issue: Health Issues Medicare/Medicaid
  • $10,000 Oct 21, 2013 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jul 21, 2013 Issue: Health Issues Medicare/Medicaid
  • $10,000 Apr 18, 2013 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues
  • $20,000 Oct 22, 2012 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 20, 2012 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 19, 2012 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 20, 2012 Issue: Health Issues Medicare/Medicaid
  • $10,000 Oct 20, 2011 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues
  • $10,000 Jul 21, 2008 Issue: Medical/Disease Research/Clinical Labs Health Issues
  • $20,000 Apr 21, 2008 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of GMED in WallStreetBets Daily Discussion

GMED News

Recent insights relating to GMED

CNBC Recommendations

Recent picks made for GMED stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GMED

GMED Top Shareholders
Shareholder
Shares Held
GMED Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GMED Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GMED Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top